Jonathan Rende, Chief Research & Development Officer at CASTLIGHT HEALTH, INC. (CSLT), sold 61,542 shares at $3.33 ($205K) on 2016-05-16, disclosed to the SEC on 2016-05-17.
Open-market sale of $205k CSLT by Chief Research & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.33 | 30,771 | $102K | 50.0% |
| 2 | $3.33 | 30,771 | $102K | 50.0% |
| Total | $3.33 avg | 61,542 | $205K | 100% |
| Filing → |
| CSLT | SELL | 2016-08-17 | $70K | — | Filing → |